BUFFALO, NY – Scott E. Friedman, chairman and CEO at Lippes Mathias Wexler Friedman LLP, is participating in Synapse Life Science Consortium’s Hamilton Health Innovation Week 2018 in Hamilton, Ontario. As part of an innovation workshop set for April 24, Mr. Friedman will share insights and guidance about establishing a U.S. presence for Canadian life science companies.

Hamilton Health Innovation Week, a week-long demonstration of the world-class health innovation happening in Hamilton, brings together public and private sector practitioners to turn inspiration into innovation that can be used by the healthcare sector to improve patient outcomes.

At Lippes Mathias, Mr. Friedman focuses his practice principally in two areas: working with entrepreneurs and family businesses, partnerships and closely held businesses across the United States on a wide range of matters relating to organizational dynamics. Mr. Friedman is a general partner and manager of Impact Capital, a WNY venture capital fund, and Buffalo Capital Partners LLC, where he enjoys working closely with startup companies.